May 17, 2012
DALLAS and NEW YORK, May 17, 2012 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop . …
May 16, 2012
Ayer Capital Partners, LLC sold 141,300 shares of Access Pharmaceuticals Inc stock, or $94,851 worth, as noted in an SEC Filing today.
As reported in the filing, t …
May 8, 2012
Access Pharmaceuticals Inc, based in DALLAS,
TX,
amended Form S-1/A
(IPO Registration (Amendment)) today.
August 15, 2011
Access Pharmaceuticals Inc filed their Quarterly Report on August 15, 2011 with the U.S. Securities and Exchange Commission.
June 1, 2011
Stephen Thompson listed their title as "CFO" at Access Pharmaceuticals Inc within the filing.
June 1, 2011
Stephen Thompson listed their title as "CFO" at Access Pharmaceuticals Inc within the filing.
June 1, 2011
David Nowotnik listed their title as "Sr. VP R&D" at Access Pharmaceuticals Inc within the filing.
June 1, 2011
David Nowotnik listed their title as "Sr. VP R&D" at Access Pharmaceuticals Inc within the filing.
June 1, 2011
Access Pharmaceuticals Inc, based in DALLAS, TX, filed an 8-K statement with the U.S. Securities Exchange Commission today.
June 1, 2011
Access Pharmaceuticals Inc, based in DALLAS, TX, filed an 8-K statement with the U.S. Securities Exchange Commission today.
May 16, 2011
Access Pharmaceuticals Inc filed their Quarterly Report on May 16, 2011 with the U.S. Securities and Exchange Commission.
May 16, 2011
Access Pharmaceuticals Inc filed their Quarterly Report on May 16, 2011 with the U.S. Securities and Exchange Commission.
April 14, 2011
Access Pharmaceuticals Inc, based in DALLAS, TX, filed Form DEF 14A (Definitive proxy statements) today.
March 31, 2011
Access Pharmaceuticals Inc filed their Annual Report on March 31, 2011 with the U.S. Securities and Exchange Commission.
March 31, 2011
Access Pharmaceuticals Inc filed their Annual Report on March 31, 2011 with the U.S. Securities and Exchange Commission.
December 14, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed an 8-K statement with the U.S. Securities Exchange Commission today.
December 14, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed an 8-K statement with the U.S. Securities Exchange Commission today.
December 14, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed Form 424B1 (Prospectus) today.
December 14, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed Form 424B1 (Prospectus) today.
December 8, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed Form EFFECT (Filing EFFECT) today.
December 8, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed Form EFFECT (Filing EFFECT) today.
December 8, 2010
ACCESS PHARMACEUTICALS INC amended their S-1 statement (IPO Registration) on December 8, 2010 with the U.S. Securities and Exchange Commission.
December 8, 2010
ACCESS PHARMACEUTICALS INC amended their S-1 statement (IPO Registration) on December 8, 2010 with the U.S. Securities and Exchange Commission.
December 7, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed Form CORRESP (Correspondence) today.
December 7, 2010
Access Pharmaceuticals Inc, based in DALLAS, TX, filed Form CORRESP (Correspondence) today.
